Management of Perforated Appendicitis with Treatment Failure on Clindamycin

Introduction to Perforated Appendicitis Treatment

• The Infectious Diseases Society of America recommends against using clindamycin as monotherapy for complicated intra-abdominal infections due to increasing resistance rates among the Bacteroides fragilis group 1
• The 2010 IDSA/SIS guidelines explicitly state that cefotetan and clindamycin are not recommended because of increasing prevalence of resistance among the B. fragilis group 1

Microbiology and Treatment

• E. coli is the most common aerobic pathogen, isolated in 71% of complicated intra-abdominal infections 1
• Standard aerobic culture techniques will not detect obligate anaerobes like B. fragilis 2
• Proper anaerobic culture requires direct inoculation of 1-10 mL of fluid into anaerobic blood culture bottles 2

Diagnosis and Management

• Negative aerobic and fungal cultures at 72 hours strongly suggest an anaerobic infection 2
• The patient's lack of improvement despite drainage and antibiotics, combined with negative aerobic cultures, is pathognomonic for inadequately treated anaerobic infection 1
• The American College of Surgeons and the Infectious Diseases Society of America recommend broad-spectrum coverage of both enteric gram-negative organisms AND anaerobes from the outset 5

Recommended Antibiotic Regimens

• Switch to metronidazole-based therapy, as metronidazole maintains uniform susceptibility against B. fragilis (93-100% sensitivity) 1
• Appropriate regimens include: piperacillin-tazobactam, ertapenem, meropenem, or combination therapy with ceftriaxone plus metronidazole, as recommended by the Infectious Diseases Society of America 1

Critical Pitfalls to Avoid

• The major error in this case was using clindamycin monotherapy for complicated intra-abdominal infection—this violates current guidelines and fails to provide adequate coverage for both resistant anaerobes and gram-negative organisms, according to the Infectious Diseases Society of America 1